Research Paper Volume 16, Issue 2 pp 1860—1878
The integration of multi-omics analysis and machine learning for the identification of prognostic assessment and immunotherapy efficacy through aging-associated genes in lung cancer
Figure 8. Differential analysis of various chemotherapeutic drugs between high and low-risk groups using the “oncopredict” package. (A–O) Higher IC50 values of different chemotherapeutic drugs in the low-risk group. (P) Higher IC50 values of chemotherapeutic drug in the high-risk group.